These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6265363)

  • 1. Effect of formalin toxoiding on Pseudomonas aeruginosa toxin A: biological, chemical, and immunochemical studies.
    Cryz SJ; Friedman RL; Pavlovskis OR; Iglewski BH
    Infect Immun; 1981 May; 32(2):759-68. PubMed ID: 6265363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoids of Pseudomonas aeruginosa toxin A: production by chemical and genetic means.
    Cryz SJ; Iglewski BH
    Rev Infect Dis; 1983; 5 Suppl 5():S992-7. PubMed ID: 6419321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization.
    Pollack M; Prescott RK
    J Infect Dis; 1982 May; 145(5):688-98. PubMed ID: 6804576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoids of Pseudomonas aeruginosa exotoxin-A: photoaffinity inactivation of purified toxin and purified toxin derivatives.
    Callahan LT; Martinez D; Marburg S; Tolman RL; Galloway DR
    Infect Immun; 1984 Mar; 43(3):1019-26. PubMed ID: 6321348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase.
    Sanai Y; Morihara K; Tsuzuki H; Homma JY; Kato I
    FEBS Lett; 1980 Oct; 120(1):131-4. PubMed ID: 6254804
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacterial protein toxins with latent ADP-ribosyl transferases activities.
    Lai CY
    Adv Enzymol Relat Areas Mol Biol; 1986; 58():99-140. PubMed ID: 3012972
    [No Abstract]   [Full Text] [Related]  

  • 7. Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa.
    Sokol PA; Iglewski BH; Hager TA; Sadoff JC; Cross AS; McManus A; Farber BF; Iglewski WJ
    Infect Immun; 1981 Oct; 34(1):147-53. PubMed ID: 6271678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.
    Pavlovskis OR; Edman DC; Leppla SH; Wretlind B; Lewis LR; Martin KE
    Infect Immun; 1981 May; 32(2):681-9. PubMed ID: 6788700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular ADP-ribosyltransferase with the same mechanism of action as diphtheria toxin and Pseudomonas toxin A.
    Lee H; Iglewski WJ
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2703-7. PubMed ID: 6326138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudomonas aeruginosa toxin A.
    Chia JK; Pollack M; Avigan D; Steinbach S
    Infect Immun; 1986 Jun; 52(3):756-62. PubMed ID: 2423458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and characterization of monoclonal antibodies to exotoxin A from Pseudomonas aeruginosa.
    Galloway DR; Hedstrom RC; Pavlovskis OR
    Infect Immun; 1984 May; 44(2):262-7. PubMed ID: 6425217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational integrity of a recombinant toxoid of Pseudomonas aeruginosa exotoxin A containing a deletion of glutamic acid-553.
    Killeen KP; Collier RJ
    Biochim Biophys Acta; 1992 Feb; 1138(2):162-6. PubMed ID: 1347236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mono (ADP-ribosyl)transferases and their effects on cellular metabolism.
    Vaughan M; Moss J
    Curr Top Cell Regul; 1981; 20():205-46. PubMed ID: 6276083
    [No Abstract]   [Full Text] [Related]  

  • 14. [Isolation of different variants of Pseudomonas aeruginosa anatoxin and their characteristics].
    Brodinova NS; Levdikova GA; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):6-12. PubMed ID: 2438865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of adult volunteers to a Pseudomonas aeruginosa exotoxoid-A vaccine.
    Lydick E; Mclean AA; Woodhour AF; Callahan LT
    J Infect Dis; 1985 Feb; 151(2):375. PubMed ID: 3918128
    [No Abstract]   [Full Text] [Related]  

  • 16. A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies.
    Coin D; Vacheron MJ; Guinand M; Michel G
    FEMS Microbiol Immunol; 1991 Aug; 3(4):185-92. PubMed ID: 1931130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of proteases on the structure and activity of Pseudomonas aeruginosa exotoxin A.
    Morihara K; Sanai Y; Tsuzuki H; Jyoyama H; Hirose K; Homma JY; Kato I
    Infect Immun; 1981 Nov; 34(2):435-40. PubMed ID: 7030958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A macromolecular structure produced by Pseudomonas aeruginosa is recognized by antibody to exotoxin A.
    Klinger KW; Shuster CW
    Infect Immun; 1984 Mar; 43(3):912-9. PubMed ID: 6421741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a small epitope in domain Ib of Pseudomonas aeruginosa exotoxin A that elicits enzyme-neutralizing antibodies.
    Rutault K; Coin D; Vacheron MJ; Guinand M; Wallach J; Michel G
    FEMS Microbiol Immunol; 1992 Jul; 4(5):267-72. PubMed ID: 1381199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence.
    Lory S; Tai PC
    Curr Top Microbiol Immunol; 1985; 118():53-69. PubMed ID: 2414071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.